| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/21/2005 | EP1576117A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 09/21/2005 | EP1576088A2 Dominant negative proteins and methods thereof |
| 09/21/2005 | EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2005 | EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 09/21/2005 | EP1575964A2 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 09/21/2005 | EP1575937A2 Rabeprazole calcium |
| 09/21/2005 | EP1575924A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
| 09/21/2005 | EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 09/21/2005 | EP1575670A2 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 09/21/2005 | EP1575608A2 Use of cc-chemokine mutants against liver diseases |
| 09/21/2005 | EP1575604A1 Antiulcer herbal composition(s) |
| 09/21/2005 | EP1575596A1 Derivatives of prostaglandins for treating abdominal discomfort |
| 09/21/2005 | EP1575552A2 Metal-containing materials, compositions and methods |
| 09/21/2005 | EP1575524A2 Proliferated cell lines and uses thereof |
| 09/21/2005 | EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof |
| 09/21/2005 | EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 09/21/2005 | EP1575480A2 Compositions and methods for the treatment of immune related diseases |
| 09/21/2005 | EP1575379A1 Nutritional compositions |
| 09/21/2005 | EP1420790B1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine |
| 09/21/2005 | EP1377560B1 Piperazine derivatives as tachykinin antagonists |
| 09/21/2005 | EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 09/21/2005 | EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists |
| 09/21/2005 | EP1220857B1 Gonadotropin releasing hormone receptor antagonists and their related methods of use |
| 09/21/2005 | EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia |
| 09/21/2005 | CN1671837A Neutralizing human anti-IGFR antibody |
| 09/21/2005 | CN1671835A A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 09/21/2005 | CN1671730A Oligonucleotide-containing pharmacological compositions and their use |
| 09/21/2005 | CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/21/2005 | CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/21/2005 | CN1671710A Pyrazolo[1, 5a]pyrimidine compounds as antiviral agents |
| 09/21/2005 | CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof |
| 09/21/2005 | CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 09/21/2005 | CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 09/21/2005 | CN1671662A Piperidine derivative, process for producing the same, and use |
| 09/21/2005 | CN1671639A Novel biphenyl and biphenyl-like cannabinoids |
| 09/21/2005 | CN1671424A Decoy composition for treating and preventing inflammatory disease |
| 09/21/2005 | CN1671421A Inclusion complexes of rosiglitazone |
| 09/21/2005 | CN1671408A Treatment of hepatitis C in the asian population with subcutaneous interferonbeta |
| 09/21/2005 | CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases |
| 09/21/2005 | CN1671396A Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 09/21/2005 | CN1671391A Novel methods and compositions for alleviating pain |
| 09/21/2005 | CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders |
| 09/21/2005 | CN1670024A Acyclic nucleoside phosphonate derivatives |
| 09/21/2005 | CN1669583A 人参胶原蛋白 Ginseng Collagen |
| 09/21/2005 | CN1669580A Compound hepatitis B quench |
| 09/21/2005 | CN1669576A Anticarious spray agent and producing process thereof |
| 09/21/2005 | CN1669574A Long acting potent kidney-invigorating and Yang-strengthening medicine and method for preparing same |
| 09/21/2005 | CN1669571A Chinese traditional medicine for treating enteritis and appendicitis, and method for preparing same |
| 09/21/2005 | CN1669567A Rough gentian soft capsule for treating hepatic diseases |
| 09/21/2005 | CN1669565A Traditional Chinese medicine preparation for treating incoordination between the spleen and the stomach, its preparation method and application |
| 09/21/2005 | CN1669553A 硫普罗宁注射液及其制备方法 Tiopronin injection and its preparation method |
| 09/21/2005 | CN1669476A Novel health food and drink containing marine algae |
| 09/21/2005 | CN1219780C Heterocyclic compounds binding chemotactic factor receptor |
| 09/21/2005 | CN1219763C Substituted indole mannich bases |
| 09/21/2005 | CN1219757C Sulfonated dehydroabietate and its preparing process and application |
| 09/21/2005 | CN1219544C Capsule for fortifying kidney and nourishing qi and its preparation method |
| 09/21/2005 | CN1219543C Chinese medicine for invigorating liver, kidney and spleen, nourishing blood, tranquilizing mind relaxing bowels and the prepn process of the Chinese medicine prepn |
| 09/21/2005 | CN1219541C Chinese medicine for invigorating vital energy and benefiting kidney and the preparation process of the granule |
| 09/21/2005 | CN1219538C Medicine for curing diarrhea and red and white dysentery |
| 09/21/2005 | CN1219530C Medicine with toxin expelling, gallbladder normalizing and liver protecting function |
| 09/21/2005 | CN1219529C Medicine for treating toothache |
| 09/21/2005 | CN1219518C Novel medical use of 2 alpha, 23- dihydroxyl ursolic acid |
| 09/21/2005 | CN1219515C In vivo stain compounds and methods of use to identify dysplastic tissue |
| 09/21/2005 | CN1219513C Application of amyl ethyl quin ether hydrochloride |
| 09/21/2005 | CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process |
| 09/21/2005 | CN1219508C Mucilage antiseptic medicine composition capable of being locally administrated and sustainably released and its preparing method |
| 09/20/2005 | US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product |
| 09/20/2005 | US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 09/20/2005 | US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/20/2005 | US6946482 Motilide compounds |
| 09/20/2005 | US6946478 Compounds |
| 09/20/2005 | US6946467 Serine protease inhibitors |
| 09/20/2005 | US6946454 Thio-oxindole derivatives |
| 09/20/2005 | US6946452 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating motion sickness |
| 09/20/2005 | US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance |
| 09/20/2005 | US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/20/2005 | US6946149 Salt solution for colon cleansing |
| 09/20/2005 | US6946129 Recombinant anti-CD40 antibody and uses thereof |
| 09/20/2005 | US6946118 comprises tetracycline derivative that is poorly absorbed from the gastrointestinal tract; may include fungicide; side effect reduction; aersols; mouthwashes |
| 09/20/2005 | CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same |
| 09/15/2005 | WO2005085418A1 Novel lactic acid bacterium |
| 09/15/2005 | WO2005085241A1 Thiazole derivative |
| 09/15/2005 | WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative |
| 09/15/2005 | WO2005085212A1 Substituted pyrimidine derivative |
| 09/15/2005 | WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient |
| 09/15/2005 | WO2005085200A1 Pyridone derivative |
| 09/15/2005 | WO2005084703A1 Sustained-release composition for oral cavity |
| 09/15/2005 | WO2005084702A1 Agent for preventing and treating organ fibrosis |
| 09/15/2005 | WO2005084662A1 The euphorbia lunulate bge extractant and production method and use thereof |
| 09/15/2005 | WO2005084649A1 Stable capsule preparation |
| 09/15/2005 | WO2005000404A3 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050203190 Methods of treating gastrointestinal tract disorders using sodium channel modulators |
| 09/15/2005 | US20050203164 Administering (4R)-[N'-methyl-N'-(3,5-bistrifluoromethyl-benzoyl)-amino]-5-(1-methyl-indol-3-yl)-pent-2-enoic acid N-[(R)-epsilon-caprolactam-3-yl]-amide; constipation, diarrhoea, functional dyspepsia, gastro-oesophageal reflux disease, functional abdominal bloating |
| 09/15/2005 | US20050203158 Substituted benzimidazole compounds |
| 09/15/2005 | US20050203154 Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 09/15/2005 | US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries |
| 09/15/2005 | US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia |
| 09/15/2005 | US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular |
| 09/15/2005 | US20050203112 Bicyclic amides |